Lista de obras - Matías Blaustein - Dominio Público Uruguay

A slow RNA polymerase II affects alternative splicing in vivo

artículo científico publicado en 2003

Akt Is S-Palmitoylated: A New Layer of Regulation for Akt

artículo científico publicado en 2021

Akt/PKB: one kinase, many modifications.

artículo científico

Argonaute-1 binds transcriptional enhancers and controls constitutive and alternative splicing in human cells

artículo científico publicado en 2014

Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT

artículo científico publicado en 2005

Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better.

artículo científico publicado en 2003

Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK.

artículo científico publicado en 2005

DNA Damage Regulates Alternative Splicing through Inhibition of RNA Polymerase II Elongation

DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation.

artículo científico publicado en 2009

Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.

scientific article published on July 2012

Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase.

artículo científico publicado en 2004

Modification of Akt by SUMO conjugation regulates alternative splicing and cell cycle

artículo científico publicado en 2013

Modulation of the Akt pathway reveals a novel link with PERK/eIF2α, which is relevant during hypoxia

artículo científico publicado en 2013

Regulation of fibronectin alternative splicing by a basement membrane-like extracellular matrix.

artículo científico publicado en 2002

Signals, pathways and splicing regulation

artículo científico publicado en 2007

Tumor necrosis factor alpha induces LIF expression through ERK1/2 activation in mammary epithelial cells

artículo científico publicado en 2010

Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda